Dual GIP/GLP-1 Drug Linked to Reduced Diabetic Retinopathy Incidence

(MedPage Today) — Use of tirzepatide (Mounjaro, Zepbound) was tied to a reduced incidence of new or progressive diabetic retinopathy and fewer complications in patients with diabetes and overweight/obesity, a retrospective study suggested.
In…

Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/119621

Author :

Publish date : 2026-01-28 14:47:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Dual GIP/GLP-1 Drug Linked to Reduced Diabetic Retinopathy Incidence

Renowned Physician Dies; Coffee and Mood Modulation; Maternal Syphilis Soars

Another Strike Sends 31,000 Kaiser Permanente Healthcare Workers to Picket Lines

Related Posts

‘Not a Little Higher. It’s Much Higher. It’s Incredible’: What We Heard This Week

The Most Honest Health Conversations May Be Those the Law Doesn’t Protect

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

Quiz Time: What Drug Was Tied to 8 Deaths?

Dulaglutide or Tirzepatide? Worldwide Biopharma Changes

Beyond the Paywall: The Cost of Lack of Research Access

‘Not a Little Higher. It’s Much Higher. It’s Incredible’: What We Heard This Week

The Most Honest Health Conversations May Be Those the Law Doesn’t Protect

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

Quiz Time: What Drug Was Tied to 8 Deaths?

Dulaglutide or Tirzepatide? Worldwide Biopharma Changes

Beyond the Paywall: The Cost of Lack of Research Access

To Fix a Patient’s Irregular Heartbeat, Doctors First Tested Its Digital ‘Twin’

An Unusual Case of Pneumonia on ‘The Pitt’: An Emergency Doctor Weighs In

Categories

Archives